Insider Transactions in Q1 2023 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,000
$12.71 P/Share
|
|
Mar 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$12,000
$12.12 P/Share
|
|
Feb 24
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$3,750
$15.39 P/Share
|
|
Feb 17
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
600
+0.02%
|
$9,600
$16.53 P/Share
|
|
Feb 10
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.04%
|
$18,000
$18.68 P/Share
|
|
Feb 03
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$5,000
$20.84 P/Share
|
|
Jan 27
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.07%
|
$38,000
$19.35 P/Share
|
|
Jan 27
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$4,750
$19.2 P/Share
|
|
Jan 20
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.05%
|
$25,500
$17.37 P/Share
|
|
Jan 13
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$4,000
$16.5 P/Share
|
|
Jan 06
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.05%
|
$22,500
$15.18 P/Share
|